Velpatasvir API Market, Global Outlook and Forecast 2022-2028
Velpatasvir(CAS?1377049-84-7) is an NS5A inhibitor (by Gilead) which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
This report contains market size and forecasts of Velpatasvir API in global, including the following market information:
Global Velpatasvir API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Velpatasvir API Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Velpatasvir API companies in 2021 (%)
The global Velpatasvir API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Above 98 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Velpatasvir API include Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd, Aspen Biopharma Labs, Aspire Lifesciences Pvt Ltd, Changzhou Pharmaceutical Factory and Bulat Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Velpatasvir API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Velpatasvir API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Velpatasvir API Market Segment Percentages, by Purity, 2021 (%)
Global Velpatasvir API Market Segment Percentages, by Application, 2021 (%)
Global Velpatasvir API Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Velpatasvir API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Velpatasvir API revenues share in global market, 2021 (%)
Key companies Velpatasvir API sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Velpatasvir API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Velpatasvir API in global, including the following market information:
Global Velpatasvir API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Velpatasvir API Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Velpatasvir API companies in 2021 (%)
The global Velpatasvir API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Above 98 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Velpatasvir API include Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd, Aspen Biopharma Labs, Aspire Lifesciences Pvt Ltd, Changzhou Pharmaceutical Factory and Bulat Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Velpatasvir API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Velpatasvir API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Velpatasvir API Market Segment Percentages, by Purity, 2021 (%)
- Above 98 %
- Above 99 %
Global Velpatasvir API Market Segment Percentages, by Application, 2021 (%)
- Tablets
- Others
Global Velpatasvir API Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Velpatasvir API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Velpatasvir API revenues share in global market, 2021 (%)
Key companies Velpatasvir API sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Velpatasvir API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mylan
- NEWEDGE Overseas
- Hetero Drugs
- Mangalam Drugs & Organics Ltd
- Aspen Biopharma Labs
- Aspire Lifesciences Pvt Ltd
- Changzhou Pharmaceutical Factory
- Bulat Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Velpatasvir API Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Velpatasvir API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VELPATASVIR API OVERALL MARKET SIZE
2.1 Global Velpatasvir API Market Size: 2021 VS 2028
2.2 Global Velpatasvir API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Velpatasvir API Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Velpatasvir API Players in Global Market
3.2 Top Global Velpatasvir API Companies Ranked by Revenue
3.3 Global Velpatasvir API Revenue by Companies
3.4 Global Velpatasvir API Sales by Companies
3.5 Global Velpatasvir API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Velpatasvir API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Velpatasvir API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Velpatasvir API Players in Global Market
3.8.1 List of Global Tier 1 Velpatasvir API Companies
3.8.2 List of Global Tier 2 and Tier 3 Velpatasvir API Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Purity - Global Velpatasvir API Market Size Markets, 2021 & 2028
4.1.2 Above 98 %
4.1.3 Above 99 %
4.2 By Purity - Global Velpatasvir API Revenue & Forecasts
4.2.1 By Purity - Global Velpatasvir API Revenue, 2017-2022
4.2.2 By Purity - Global Velpatasvir API Revenue, 2023-2028
4.2.3 By Purity - Global Velpatasvir API Revenue Market Share, 2017-2028
4.3 By Purity - Global Velpatasvir API Sales & Forecasts
4.3.1 By Purity - Global Velpatasvir API Sales, 2017-2022
4.3.2 By Purity - Global Velpatasvir API Sales, 2023-2028
4.3.3 By Purity - Global Velpatasvir API Sales Market Share, 2017-2028
4.4 By Purity - Global Velpatasvir API Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Velpatasvir API Market Size, 2021 & 2028
5.1.2 Tablets
5.1.3 Others
5.2 By Application - Global Velpatasvir API Revenue & Forecasts
5.2.1 By Application - Global Velpatasvir API Revenue, 2017-2022
5.2.2 By Application - Global Velpatasvir API Revenue, 2023-2028
5.2.3 By Application - Global Velpatasvir API Revenue Market Share, 2017-2028
5.3 By Application - Global Velpatasvir API Sales & Forecasts
5.3.1 By Application - Global Velpatasvir API Sales, 2017-2022
5.3.2 By Application - Global Velpatasvir API Sales, 2023-2028
5.3.3 By Application - Global Velpatasvir API Sales Market Share, 2017-2028
5.4 By Application - Global Velpatasvir API Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Velpatasvir API Market Size, 2021 & 2028
6.2 By Region - Global Velpatasvir API Revenue & Forecasts
6.2.1 By Region - Global Velpatasvir API Revenue, 2017-2022
6.2.2 By Region - Global Velpatasvir API Revenue, 2023-2028
6.2.3 By Region - Global Velpatasvir API Revenue Market Share, 2017-2028
6.3 By Region - Global Velpatasvir API Sales & Forecasts
6.3.1 By Region - Global Velpatasvir API Sales, 2017-2022
6.3.2 By Region - Global Velpatasvir API Sales, 2023-2028
6.3.3 By Region - Global Velpatasvir API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Velpatasvir API Revenue, 2017-2028
6.4.2 By Country - North America Velpatasvir API Sales, 2017-2028
6.4.3 US Velpatasvir API Market Size, 2017-2028
6.4.4 Canada Velpatasvir API Market Size, 2017-2028
6.4.5 Mexico Velpatasvir API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Velpatasvir API Revenue, 2017-2028
6.5.2 By Country - Europe Velpatasvir API Sales, 2017-2028
6.5.3 Germany Velpatasvir API Market Size, 2017-2028
6.5.4 France Velpatasvir API Market Size, 2017-2028
6.5.5 U.K. Velpatasvir API Market Size, 2017-2028
6.5.6 Italy Velpatasvir API Market Size, 2017-2028
6.5.7 Russia Velpatasvir API Market Size, 2017-2028
6.5.8 Nordic Countries Velpatasvir API Market Size, 2017-2028
6.5.9 Benelux Velpatasvir API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Velpatasvir API Revenue, 2017-2028
6.6.2 By Region - Asia Velpatasvir API Sales, 2017-2028
6.6.3 China Velpatasvir API Market Size, 2017-2028
6.6.4 Japan Velpatasvir API Market Size, 2017-2028
6.6.5 South Korea Velpatasvir API Market Size, 2017-2028
6.6.6 Southeast Asia Velpatasvir API Market Size, 2017-2028
6.6.7 India Velpatasvir API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Velpatasvir API Revenue, 2017-2028
6.7.2 By Country - South America Velpatasvir API Sales, 2017-2028
6.7.3 Brazil Velpatasvir API Market Size, 2017-2028
6.7.4 Argentina Velpatasvir API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Velpatasvir API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Velpatasvir API Sales, 2017-2028
6.8.3 Turkey Velpatasvir API Market Size, 2017-2028
6.8.4 Israel Velpatasvir API Market Size, 2017-2028
6.8.5 Saudi Arabia Velpatasvir API Market Size, 2017-2028
6.8.6 UAE Velpatasvir API Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Mylan
7.1.1 Mylan Corporate Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Velpatasvir API Major Product Offerings
7.1.4 Mylan Velpatasvir API Sales and Revenue in Global (2017-2022)
7.1.5 Mylan Key News
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Corporate Summary
7.2.2 NEWEDGE Overseas Business Overview
7.2.3 NEWEDGE Overseas Velpatasvir API Major Product Offerings
7.2.4 NEWEDGE Overseas Velpatasvir API Sales and Revenue in Global (2017-2022)
7.2.5 NEWEDGE Overseas Key News
7.3 Hetero Drugs
7.3.1 Hetero Drugs Corporate Summary
7.3.2 Hetero Drugs Business Overview
7.3.3 Hetero Drugs Velpatasvir API Major Product Offerings
7.3.4 Hetero Drugs Velpatasvir API Sales and Revenue in Global (2017-2022)
7.3.5 Hetero Drugs Key News
7.4 Mangalam Drugs & Organics Ltd
7.4.1 Mangalam Drugs & Organics Ltd Corporate Summary
7.4.2 Mangalam Drugs & Organics Ltd Business Overview
7.4.3 Mangalam Drugs & Organics Ltd Velpatasvir API Major Product Offerings
7.4.4 Mangalam Drugs & Organics Ltd Velpatasvir API Sales and Revenue in Global (2017-2022)
7.4.5 Mangalam Drugs & Organics Ltd Key News
7.5 Aspen Biopharma Labs
7.5.1 Aspen Biopharma Labs Corporate Summary
7.5.2 Aspen Biopharma Labs Business Overview
7.5.3 Aspen Biopharma Labs Velpatasvir API Major Product Offerings
7.5.4 Aspen Biopharma Labs Velpatasvir API Sales and Revenue in Global (2017-2022)
7.5.5 Aspen Biopharma Labs Key News
7.6 Aspire Lifesciences Pvt Ltd
7.6.1 Aspire Lifesciences Pvt Ltd Corporate Summary
7.6.2 Aspire Lifesciences Pvt Ltd Business Overview
7.6.3 Aspire Lifesciences Pvt Ltd Velpatasvir API Major Product Offerings
7.6.4 Aspire Lifesciences Pvt Ltd Velpatasvir API Sales and Revenue in Global (2017-2022)
7.6.5 Aspire Lifesciences Pvt Ltd Key News
7.7 Changzhou Pharmaceutical Factory
7.7.1 Changzhou Pharmaceutical Factory Corporate Summary
7.7.2 Changzhou Pharmaceutical Factory Business Overview
7.7.3 Changzhou Pharmaceutical Factory Velpatasvir API Major Product Offerings
7.7.4 Changzhou Pharmaceutical Factory Velpatasvir API Sales and Revenue in Global (2017-2022)
7.7.5 Changzhou Pharmaceutical Factory Key News
7.8 Bulat Pharmaceutical
7.8.1 Bulat Pharmaceutical Corporate Summary
7.8.2 Bulat Pharmaceutical Business Overview
7.8.3 Bulat Pharmaceutical Velpatasvir API Major Product Offerings
7.8.4 Bulat Pharmaceutical Velpatasvir API Sales and Revenue in Global (2017-2022)
7.8.5 Bulat Pharmaceutical Key News
8 GLOBAL VELPATASVIR API PRODUCTION CAPACITY, ANALYSIS
8.1 Global Velpatasvir API Production Capacity, 2017-2028
8.2 Velpatasvir API Production Capacity of Key Manufacturers in Global Market
8.3 Global Velpatasvir API Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 VELPATASVIR API SUPPLY CHAIN ANALYSIS
10.1 Velpatasvir API Industry Value Chain
10.2 Velpatasvir API Upstream Market
10.3 Velpatasvir API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Velpatasvir API Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Velpatasvir API Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Velpatasvir API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VELPATASVIR API OVERALL MARKET SIZE
2.1 Global Velpatasvir API Market Size: 2021 VS 2028
2.2 Global Velpatasvir API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Velpatasvir API Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Velpatasvir API Players in Global Market
3.2 Top Global Velpatasvir API Companies Ranked by Revenue
3.3 Global Velpatasvir API Revenue by Companies
3.4 Global Velpatasvir API Sales by Companies
3.5 Global Velpatasvir API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Velpatasvir API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Velpatasvir API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Velpatasvir API Players in Global Market
3.8.1 List of Global Tier 1 Velpatasvir API Companies
3.8.2 List of Global Tier 2 and Tier 3 Velpatasvir API Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Purity - Global Velpatasvir API Market Size Markets, 2021 & 2028
4.1.2 Above 98 %
4.1.3 Above 99 %
4.2 By Purity - Global Velpatasvir API Revenue & Forecasts
4.2.1 By Purity - Global Velpatasvir API Revenue, 2017-2022
4.2.2 By Purity - Global Velpatasvir API Revenue, 2023-2028
4.2.3 By Purity - Global Velpatasvir API Revenue Market Share, 2017-2028
4.3 By Purity - Global Velpatasvir API Sales & Forecasts
4.3.1 By Purity - Global Velpatasvir API Sales, 2017-2022
4.3.2 By Purity - Global Velpatasvir API Sales, 2023-2028
4.3.3 By Purity - Global Velpatasvir API Sales Market Share, 2017-2028
4.4 By Purity - Global Velpatasvir API Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Velpatasvir API Market Size, 2021 & 2028
5.1.2 Tablets
5.1.3 Others
5.2 By Application - Global Velpatasvir API Revenue & Forecasts
5.2.1 By Application - Global Velpatasvir API Revenue, 2017-2022
5.2.2 By Application - Global Velpatasvir API Revenue, 2023-2028
5.2.3 By Application - Global Velpatasvir API Revenue Market Share, 2017-2028
5.3 By Application - Global Velpatasvir API Sales & Forecasts
5.3.1 By Application - Global Velpatasvir API Sales, 2017-2022
5.3.2 By Application - Global Velpatasvir API Sales, 2023-2028
5.3.3 By Application - Global Velpatasvir API Sales Market Share, 2017-2028
5.4 By Application - Global Velpatasvir API Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Velpatasvir API Market Size, 2021 & 2028
6.2 By Region - Global Velpatasvir API Revenue & Forecasts
6.2.1 By Region - Global Velpatasvir API Revenue, 2017-2022
6.2.2 By Region - Global Velpatasvir API Revenue, 2023-2028
6.2.3 By Region - Global Velpatasvir API Revenue Market Share, 2017-2028
6.3 By Region - Global Velpatasvir API Sales & Forecasts
6.3.1 By Region - Global Velpatasvir API Sales, 2017-2022
6.3.2 By Region - Global Velpatasvir API Sales, 2023-2028
6.3.3 By Region - Global Velpatasvir API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Velpatasvir API Revenue, 2017-2028
6.4.2 By Country - North America Velpatasvir API Sales, 2017-2028
6.4.3 US Velpatasvir API Market Size, 2017-2028
6.4.4 Canada Velpatasvir API Market Size, 2017-2028
6.4.5 Mexico Velpatasvir API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Velpatasvir API Revenue, 2017-2028
6.5.2 By Country - Europe Velpatasvir API Sales, 2017-2028
6.5.3 Germany Velpatasvir API Market Size, 2017-2028
6.5.4 France Velpatasvir API Market Size, 2017-2028
6.5.5 U.K. Velpatasvir API Market Size, 2017-2028
6.5.6 Italy Velpatasvir API Market Size, 2017-2028
6.5.7 Russia Velpatasvir API Market Size, 2017-2028
6.5.8 Nordic Countries Velpatasvir API Market Size, 2017-2028
6.5.9 Benelux Velpatasvir API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Velpatasvir API Revenue, 2017-2028
6.6.2 By Region - Asia Velpatasvir API Sales, 2017-2028
6.6.3 China Velpatasvir API Market Size, 2017-2028
6.6.4 Japan Velpatasvir API Market Size, 2017-2028
6.6.5 South Korea Velpatasvir API Market Size, 2017-2028
6.6.6 Southeast Asia Velpatasvir API Market Size, 2017-2028
6.6.7 India Velpatasvir API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Velpatasvir API Revenue, 2017-2028
6.7.2 By Country - South America Velpatasvir API Sales, 2017-2028
6.7.3 Brazil Velpatasvir API Market Size, 2017-2028
6.7.4 Argentina Velpatasvir API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Velpatasvir API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Velpatasvir API Sales, 2017-2028
6.8.3 Turkey Velpatasvir API Market Size, 2017-2028
6.8.4 Israel Velpatasvir API Market Size, 2017-2028
6.8.5 Saudi Arabia Velpatasvir API Market Size, 2017-2028
6.8.6 UAE Velpatasvir API Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Mylan
7.1.1 Mylan Corporate Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Velpatasvir API Major Product Offerings
7.1.4 Mylan Velpatasvir API Sales and Revenue in Global (2017-2022)
7.1.5 Mylan Key News
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Corporate Summary
7.2.2 NEWEDGE Overseas Business Overview
7.2.3 NEWEDGE Overseas Velpatasvir API Major Product Offerings
7.2.4 NEWEDGE Overseas Velpatasvir API Sales and Revenue in Global (2017-2022)
7.2.5 NEWEDGE Overseas Key News
7.3 Hetero Drugs
7.3.1 Hetero Drugs Corporate Summary
7.3.2 Hetero Drugs Business Overview
7.3.3 Hetero Drugs Velpatasvir API Major Product Offerings
7.3.4 Hetero Drugs Velpatasvir API Sales and Revenue in Global (2017-2022)
7.3.5 Hetero Drugs Key News
7.4 Mangalam Drugs & Organics Ltd
7.4.1 Mangalam Drugs & Organics Ltd Corporate Summary
7.4.2 Mangalam Drugs & Organics Ltd Business Overview
7.4.3 Mangalam Drugs & Organics Ltd Velpatasvir API Major Product Offerings
7.4.4 Mangalam Drugs & Organics Ltd Velpatasvir API Sales and Revenue in Global (2017-2022)
7.4.5 Mangalam Drugs & Organics Ltd Key News
7.5 Aspen Biopharma Labs
7.5.1 Aspen Biopharma Labs Corporate Summary
7.5.2 Aspen Biopharma Labs Business Overview
7.5.3 Aspen Biopharma Labs Velpatasvir API Major Product Offerings
7.5.4 Aspen Biopharma Labs Velpatasvir API Sales and Revenue in Global (2017-2022)
7.5.5 Aspen Biopharma Labs Key News
7.6 Aspire Lifesciences Pvt Ltd
7.6.1 Aspire Lifesciences Pvt Ltd Corporate Summary
7.6.2 Aspire Lifesciences Pvt Ltd Business Overview
7.6.3 Aspire Lifesciences Pvt Ltd Velpatasvir API Major Product Offerings
7.6.4 Aspire Lifesciences Pvt Ltd Velpatasvir API Sales and Revenue in Global (2017-2022)
7.6.5 Aspire Lifesciences Pvt Ltd Key News
7.7 Changzhou Pharmaceutical Factory
7.7.1 Changzhou Pharmaceutical Factory Corporate Summary
7.7.2 Changzhou Pharmaceutical Factory Business Overview
7.7.3 Changzhou Pharmaceutical Factory Velpatasvir API Major Product Offerings
7.7.4 Changzhou Pharmaceutical Factory Velpatasvir API Sales and Revenue in Global (2017-2022)
7.7.5 Changzhou Pharmaceutical Factory Key News
7.8 Bulat Pharmaceutical
7.8.1 Bulat Pharmaceutical Corporate Summary
7.8.2 Bulat Pharmaceutical Business Overview
7.8.3 Bulat Pharmaceutical Velpatasvir API Major Product Offerings
7.8.4 Bulat Pharmaceutical Velpatasvir API Sales and Revenue in Global (2017-2022)
7.8.5 Bulat Pharmaceutical Key News
8 GLOBAL VELPATASVIR API PRODUCTION CAPACITY, ANALYSIS
8.1 Global Velpatasvir API Production Capacity, 2017-2028
8.2 Velpatasvir API Production Capacity of Key Manufacturers in Global Market
8.3 Global Velpatasvir API Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 VELPATASVIR API SUPPLY CHAIN ANALYSIS
10.1 Velpatasvir API Industry Value Chain
10.2 Velpatasvir API Upstream Market
10.3 Velpatasvir API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Velpatasvir API Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Velpatasvir API in Global Market
Table 2. Top Velpatasvir API Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Velpatasvir API Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Velpatasvir API Revenue Share by Companies, 2017-2022
Table 5. Global Velpatasvir API Sales by Companies, (Kg), 2017-2022
Table 6. Global Velpatasvir API Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Velpatasvir API Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Velpatasvir API Product Type
Table 9. List of Global Tier 1 Velpatasvir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Velpatasvir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Purity – Global Velpatasvir API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Purity - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 13. By Purity - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 14. By Purity - Global Velpatasvir API Sales (Kg), 2017-2022
Table 15. By Purity - Global Velpatasvir API Sales (Kg), 2023-2028
Table 16. By Application – Global Velpatasvir API Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Velpatasvir API Sales (Kg), 2017-2022
Table 20. By Application - Global Velpatasvir API Sales (Kg), 2023-2028
Table 21. By Region – Global Velpatasvir API Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Velpatasvir API Sales (Kg), 2017-2022
Table 25. By Region - Global Velpatasvir API Sales (Kg), 2023-2028
Table 26. By Country - North America Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Velpatasvir API Sales, (Kg), 2017-2022
Table 29. By Country - North America Velpatasvir API Sales, (Kg), 2023-2028
Table 30. By Country - Europe Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Velpatasvir API Sales, (Kg), 2017-2022
Table 33. By Country - Europe Velpatasvir API Sales, (Kg), 2023-2028
Table 34. By Region - Asia Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Velpatasvir API Sales, (Kg), 2017-2022
Table 37. By Region - Asia Velpatasvir API Sales, (Kg), 2023-2028
Table 38. By Country - South America Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Velpatasvir API Sales, (Kg), 2017-2022
Table 41. By Country - South America Velpatasvir API Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Velpatasvir API Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Velpatasvir API Sales, (Kg), 2023-2028
Table 46. Mylan Corporate Summary
Table 47. Mylan Velpatasvir API Product Offerings
Table 48. Mylan Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. NEWEDGE Overseas Corporate Summary
Table 50. NEWEDGE Overseas Velpatasvir API Product Offerings
Table 51. NEWEDGE Overseas Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Hetero Drugs Corporate Summary
Table 53. Hetero Drugs Velpatasvir API Product Offerings
Table 54. Hetero Drugs Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Mangalam Drugs & Organics Ltd Corporate Summary
Table 56. Mangalam Drugs & Organics Ltd Velpatasvir API Product Offerings
Table 57. Mangalam Drugs & Organics Ltd Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Aspen Biopharma Labs Corporate Summary
Table 59. Aspen Biopharma Labs Velpatasvir API Product Offerings
Table 60. Aspen Biopharma Labs Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Aspire Lifesciences Pvt Ltd Corporate Summary
Table 62. Aspire Lifesciences Pvt Ltd Velpatasvir API Product Offerings
Table 63. Aspire Lifesciences Pvt Ltd Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Changzhou Pharmaceutical Factory Corporate Summary
Table 65. Changzhou Pharmaceutical Factory Velpatasvir API Product Offerings
Table 66. Changzhou Pharmaceutical Factory Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Bulat Pharmaceutical Corporate Summary
Table 68. Bulat Pharmaceutical Velpatasvir API Product Offerings
Table 69. Bulat Pharmaceutical Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Velpatasvir API Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 71. Global Velpatasvir API Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Velpatasvir API Production by Region, 2017-2022 (Kg)
Table 73. Global Velpatasvir API Production by Region, 2023-2028 (Kg)
Table 74. Velpatasvir API Market Opportunities & Trends in Global Market
Table 75. Velpatasvir API Market Drivers in Global Market
Table 76. Velpatasvir API Market Restraints in Global Market
Table 77. Velpatasvir API Raw Materials
Table 78. Velpatasvir API Raw Materials Suppliers in Global Market
Table 79. Typical Velpatasvir API Downstream
Table 80. Velpatasvir API Downstream Clients in Global Market
Table 81. Velpatasvir API Distributors and Sales Agents in Global Market
Table 1. Key Players of Velpatasvir API in Global Market
Table 2. Top Velpatasvir API Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Velpatasvir API Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Velpatasvir API Revenue Share by Companies, 2017-2022
Table 5. Global Velpatasvir API Sales by Companies, (Kg), 2017-2022
Table 6. Global Velpatasvir API Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Velpatasvir API Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Velpatasvir API Product Type
Table 9. List of Global Tier 1 Velpatasvir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Velpatasvir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Purity – Global Velpatasvir API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Purity - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 13. By Purity - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 14. By Purity - Global Velpatasvir API Sales (Kg), 2017-2022
Table 15. By Purity - Global Velpatasvir API Sales (Kg), 2023-2028
Table 16. By Application – Global Velpatasvir API Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Velpatasvir API Sales (Kg), 2017-2022
Table 20. By Application - Global Velpatasvir API Sales (Kg), 2023-2028
Table 21. By Region – Global Velpatasvir API Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Velpatasvir API Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Velpatasvir API Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Velpatasvir API Sales (Kg), 2017-2022
Table 25. By Region - Global Velpatasvir API Sales (Kg), 2023-2028
Table 26. By Country - North America Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Velpatasvir API Sales, (Kg), 2017-2022
Table 29. By Country - North America Velpatasvir API Sales, (Kg), 2023-2028
Table 30. By Country - Europe Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Velpatasvir API Sales, (Kg), 2017-2022
Table 33. By Country - Europe Velpatasvir API Sales, (Kg), 2023-2028
Table 34. By Region - Asia Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Velpatasvir API Sales, (Kg), 2017-2022
Table 37. By Region - Asia Velpatasvir API Sales, (Kg), 2023-2028
Table 38. By Country - South America Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Velpatasvir API Sales, (Kg), 2017-2022
Table 41. By Country - South America Velpatasvir API Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Velpatasvir API Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Velpatasvir API Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Velpatasvir API Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Velpatasvir API Sales, (Kg), 2023-2028
Table 46. Mylan Corporate Summary
Table 47. Mylan Velpatasvir API Product Offerings
Table 48. Mylan Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. NEWEDGE Overseas Corporate Summary
Table 50. NEWEDGE Overseas Velpatasvir API Product Offerings
Table 51. NEWEDGE Overseas Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Hetero Drugs Corporate Summary
Table 53. Hetero Drugs Velpatasvir API Product Offerings
Table 54. Hetero Drugs Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Mangalam Drugs & Organics Ltd Corporate Summary
Table 56. Mangalam Drugs & Organics Ltd Velpatasvir API Product Offerings
Table 57. Mangalam Drugs & Organics Ltd Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Aspen Biopharma Labs Corporate Summary
Table 59. Aspen Biopharma Labs Velpatasvir API Product Offerings
Table 60. Aspen Biopharma Labs Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Aspire Lifesciences Pvt Ltd Corporate Summary
Table 62. Aspire Lifesciences Pvt Ltd Velpatasvir API Product Offerings
Table 63. Aspire Lifesciences Pvt Ltd Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Changzhou Pharmaceutical Factory Corporate Summary
Table 65. Changzhou Pharmaceutical Factory Velpatasvir API Product Offerings
Table 66. Changzhou Pharmaceutical Factory Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Bulat Pharmaceutical Corporate Summary
Table 68. Bulat Pharmaceutical Velpatasvir API Product Offerings
Table 69. Bulat Pharmaceutical Velpatasvir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Velpatasvir API Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 71. Global Velpatasvir API Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Velpatasvir API Production by Region, 2017-2022 (Kg)
Table 73. Global Velpatasvir API Production by Region, 2023-2028 (Kg)
Table 74. Velpatasvir API Market Opportunities & Trends in Global Market
Table 75. Velpatasvir API Market Drivers in Global Market
Table 76. Velpatasvir API Market Restraints in Global Market
Table 77. Velpatasvir API Raw Materials
Table 78. Velpatasvir API Raw Materials Suppliers in Global Market
Table 79. Typical Velpatasvir API Downstream
Table 80. Velpatasvir API Downstream Clients in Global Market
Table 81. Velpatasvir API Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Velpatasvir API Segment by Purity
Figure 2. Velpatasvir API Segment by Application
Figure 3. Global Velpatasvir API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Velpatasvir API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Velpatasvir API Revenue, 2017-2028 (US$, Mn)
Figure 7. Velpatasvir API Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Velpatasvir API Revenue in 2021
Figure 9. By Purity - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 10. By Purity - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 11. By Purity - Global Velpatasvir API Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 13. By Application - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 14. By Application - Global Velpatasvir API Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 16. By Region - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 17. By Country - North America Velpatasvir API Revenue Market Share, 2017-2028
Figure 18. By Country - North America Velpatasvir API Sales Market Share, 2017-2028
Figure 19. US Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Velpatasvir API Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Velpatasvir API Sales Market Share, 2017-2028
Figure 24. Germany Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 25. France Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Velpatasvir API Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Velpatasvir API Sales Market Share, 2017-2028
Figure 33. China Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 37. India Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Velpatasvir API Revenue Market Share, 2017-2028
Figure 39. By Country - South America Velpatasvir API Sales Market Share, 2017-2028
Figure 40. Brazil Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Velpatasvir API Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Velpatasvir API Sales Market Share, 2017-2028
Figure 44. Turkey Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 48. Global Velpatasvir API Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Velpatasvir API by Region, 2021 VS 2028
Figure 50. Velpatasvir API Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Velpatasvir API Segment by Purity
Figure 2. Velpatasvir API Segment by Application
Figure 3. Global Velpatasvir API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Velpatasvir API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Velpatasvir API Revenue, 2017-2028 (US$, Mn)
Figure 7. Velpatasvir API Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Velpatasvir API Revenue in 2021
Figure 9. By Purity - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 10. By Purity - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 11. By Purity - Global Velpatasvir API Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 13. By Application - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 14. By Application - Global Velpatasvir API Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Velpatasvir API Sales Market Share, 2017-2028
Figure 16. By Region - Global Velpatasvir API Revenue Market Share, 2017-2028
Figure 17. By Country - North America Velpatasvir API Revenue Market Share, 2017-2028
Figure 18. By Country - North America Velpatasvir API Sales Market Share, 2017-2028
Figure 19. US Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Velpatasvir API Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Velpatasvir API Sales Market Share, 2017-2028
Figure 24. Germany Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 25. France Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Velpatasvir API Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Velpatasvir API Sales Market Share, 2017-2028
Figure 33. China Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 37. India Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Velpatasvir API Revenue Market Share, 2017-2028
Figure 39. By Country - South America Velpatasvir API Sales Market Share, 2017-2028
Figure 40. Brazil Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Velpatasvir API Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Velpatasvir API Sales Market Share, 2017-2028
Figure 44. Turkey Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Velpatasvir API Revenue, (US$, Mn), 2017-2028
Figure 48. Global Velpatasvir API Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Velpatasvir API by Region, 2021 VS 2028
Figure 50. Velpatasvir API Industry Value Chain
Figure 51. Marketing Channels
